Menu
About Us
Our Purpose, Mission and Values
Our Story So Far
Our Leadership Team
Videos & Presentations
Lung Cancer
Key Statistics
Our LungLB® Test
Informative Videos
News
RNS Announcements
Press Inquiries
Investors
Description of the Business
Directors
Corporate Governance
Company Information
Shareholder Information
Financial Information
Advisors
Contact Us
close
Introduction to LungLife AI, Inc post Admission
July 9, 2021
Paul Pagano talks with Paul Hill of VOX Markets following the Company's IPO on 8 July, 2021.
Recent Presentations
Presentation: Audited results for the year ended 31 December 2023
April 8, 2024
Presentation: Half-year report for the six months ended 30 June 2023
August 9, 2023
Q&A with Lunglife AI's CEO, Paul Pagano
August 8, 2023
Media
»
Introduction to LungLife AI, Inc post Admission
LungLife AI licensure/accreditation information posted here.
© 2023 LungLIfe AI, Inc.
All rights reserved. LiquidBiopsy is a trademark of LungLife AI, Inc.
close
bars
linkedin
chevron-down
LungLife AI licensure/accreditation information posted here.